OUR HISTORY
Long-Time Innovator in Oncology
2006
M2GEN (now Aster Insights) is founded
First patient enrolled in Total Cancer Care® (TCC)
2012
Merck uses our data to lay path for KEYTRUDA® development
2014
Oncology Research Information Exchange Network (ORIEN®) consortium established
2018
ORIEN® expands and adds community partnership
2021
Exceeded 100 publications from TCC®
2022
Exceeded 150 cumulative ORIEN® research collaborations
2023
400,000 patients accrued in TCC®